fenofibrate has been researched along with Pneumonia, Viral in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fenofibrate, which is a PPAR-alfpha agonist, increases the level of sulfatide." | 1.56 | Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19. ( Buschard, K, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buschard, K | 1 |
| Heffernan, KS | 1 |
| Ranadive, SM | 1 |
| Jae, SY | 1 |
2 other studies available for fenofibrate and Pneumonia, Viral
| Article | Year |
|---|---|
Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19.
Topics: Adult; Aging; Betacoronavirus; Child; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dru | 2020 |
Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy.
Topics: Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytoplasm; | 2020 |